Modulation of electroconvulsive treatment induced β-adrenergic down-regulation by previous chronic imipramine administration: The involvement of protein kinase C

Polish Journal of Pharmacology

Volumn 48, Issue 5, 1996, Pages 489-494

  Nalepa, Irena ^a   Vetulani, Jerzy ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

down regulation; cyclic AMP; electroconvulsive treatment; imipramine; phorbol ester; protein kinase C

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; IMIPRAMINE; ISOPRENALINE; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; CONVULSION; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECEPTOR DOWN REGULATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLIC AMP; DOWN-REGULATION; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVATION; IMIPRAMINE; ISOPROTERENOL; MALE; NOREPINEPHRINE; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA;

EID: 0030481292     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Azzi A., Boscoboinik D., Hensey C.: The protein kinase C family. Eur. J. Biochem., 1992, 208, 547-557.
2. Blendy J. A., Stockmeier C. A., Kellar K. J.: Electroconvulsive shock and reserpine increase alpha 1-adrenoceptor binding sites but not norepinephrine-stimulated phosphoinositide hydrolysis in rat brain. Eur. J. Pharmacol., 1988, 156, 267-270.
3. 2-adrenergic receptors by protein kinase C and the cyclic AMP-dependent protein kinase. J. Biol. Chem., 1987, 262, 3106-3113.
4. Campbell I. C., McKeman R. M.: Central and peripheral changes in α-adrenoceptors in the rat in response to chronic antidepressant drug administration. Adv. Biosci., 1982, 40, 153-160.
5. Cohen R. M., Campbell I. C, Dauphin M., Tallaman J. F., Murphy D. L.: Changes in α- and β-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants. Neuropharmacology, 1982, 21, 293-298.
6. Daly J. W., Padgett W. C., Creveling R., Cantacuzene D., Kirk K. L.: Cyclic AMP-generating systems: regional differences in activation by adrenergic receptors in rat brain. J. Neurosci., 1981, 1, 45-59.
7. Fink M.: Efficacy of ECT. Lancet, 1979, 1, 1303-1304.
8. Gleiter C H., Nutt D. J.: Chronic electroconvulsive shock and neurotransmitter receptors - an update. Life Sci., 1989, 44, 985-1006.
9. 2+ in smooth muscle. Nature, 1987, 329, 333-335.
10. Hayakawa H., Shimizu M., Yamawaki S.: The effects of electroconvulsive shock or imipramine on subtypes of α-adrenoceptors in the frontal cortex of the rat. Neuropharmacology, 1992, 31, 955-960.
11. Hosoda K., Duman R. S.: Regulation of betal-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J. Neurochem., 1993, 60, 1335-1343.
12. 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism. Proc. Nat. Acad. Sci. USA, 1985, 82, 5651-5655.
13. Li P. P., Warsh J. J., Sibony D., Chiu A.: Assessment of rat brain alpha 1-adrenoceptor binding and activation of inositol phospholipid turnover following chronic imipramine treatment Neurochem. Res., 1985, 13, 1111-1118.
14. Nalepa I.: The effect of psychotropic drugs on the interaction of protein kinase C with second messenger systems in the rat cerebral cortex. Pol. J. Pharmacol., 1994, 46, 1-14.
15. 1-adrenoceptor activity by protein kinase C. Pol. J. Pharmacol., 1993, 45, 521-532.
16. Nalepa I., Chalecka-Franaszek E., Vetulani J.: Electroconvulsive shock treatment: opposite effects on mianserin and imipramine-induced changes of alpha1-adrenoceptor system. Neuropsychopharmacology, 1994, 10 Suppl., Part 2, 106S.
17. Nalepa I., Chalecka-Franaszek E., Vetulani J.: Modulation by mianserin pretreatment of the chronic electroconvulsive shock effects on the adrenergic system in the cerebral cortex of the rat. Human Psychopharmacol. Clin. Exp., 1996, 11, 273-282.
18. Nalepa I., Vetulani J.: Different mechanisms of β-adrenoceptor down-regulation by chronic imipramine and electroconvulsive treatment: possible role for protein kinase C. J. Neurochem., 1991, 57, 904-910.
19. Nalepa I., Vetulani J.: Involvement of protein kinase C in the mechanisms of in vitro effects of imipramine on generation of second messengers by noradrenaline in the cerebral cortical slices of the rat. Neuroscience, 1991, 44, 585-590.
20. Nalepa I., Vetulani J.: Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of an atypical antidepressant citalopram. J. Neurochem., 1993, 60, 2029-2035.
21. Newman M. E., Miskin I., Lerer B.: Effects of single and repeated electroconvulsive shock administration on inositol phosphate accumulation in rat brain slices. J. Neurochem., 1987, 49, 19-23.
22. Nishizuka Y.: Turnover of inositol phospholipids and signal transduction. Science, 1984, 225, 1365-1370.
23. 1-adrenoceptors following destruction of noradrenergic or serotonergic nerve terminals. Pol. J. Pharmacol. Pharm., 1988, 40, 393-400.
24. Salomon Y., Londos C., Rodbell M.: A highly sensitive adenylate cyclase assay. Anal. Biochem., 1974, 58, 541-548.
25. Shimizu H., Daly J., Crevelling C. R.: A radioisotopic method for measuring formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain. J. Neurochem., 1969, 16, 1609-1619.
26. Stockmeier C. A., McLeskey S. W., Blendy J. A., Armstrong N. R., Kellar K. J.: Electroconvulsive shock but not antidepressant drugs increases alpha-1 adrenoceptor binding sites in rat brain. Eur. J. Pharmacol., 1987, 139, 259-266.
27. Sugden D., Klein D. C.: Activators of protein kinase C act at a postreceptor site to amplify cyclic AMP production in rat pinealocytes. J. Neurochem., 1988, 50, 149-155.
28. Vetulani J.: Complex action of antidepressant treatment on central adrenergic system: possible relevance to clinical effects. Pharmacopsychiatry, 1984, 17, 16-21.
29. Vetulani J.: Changes in responsiveness of central aminergic structures after chronic ECS. In: ECT: Basic Mechanisms. Eds. Lerer B., Weiner R. D., Belmaker R. H., Libbey, London, 1984, 33-45.
30. Vetulani J.: The development of our understanding of the mechanism of action of antidepressant drugs. Pol. J. Pharmacol. Pharm., 1991, 43, 323-338.
31. 3H]prazosin binding sites in the central nervous system of the rat. Brain Res., 1983, 275, 392-395.
32. Vetulani J., Nalepa I., Popik P.: Strain differences in changes of some parameters of cortical adrenergic system following chronic imipramine administration to rats. Pol. J. Pharmacol. Pharm., 1991, 43, 187-195.
33. Vetulani J., Stawarz R. J., Dingell J. V., Sulser R: A possible common mechanism of action of antidepressant treatments. Reduction in the sensitivity of the noradrenergic cyclic AMP generating system in the rat limbic forebrain. Naunyn-Schmied. Arch. Pharmacol., 1976, 293, 109-114.
34. Vetulani J., Sulser F.: Action of various antidepressant treatment reduces reactivity of noradrenergic cyclic AMP generating system in limbic forebrain. Nature, 1975, 257, 495-496.